Roivant Sciences Ltd (ROIV) — Financial Flexibility Index
Roivant Sciences Ltd (ROIV) has a Financial Flexibility Index of -0.76x as of December 2025. Free cash flow of $-191.55 Million (operating CF $-196.48 Million minus capex $4.93 Million) represents -1% of total liabilities ($251.14 Million). Check asset allocation strategy of Roivant Sciences Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Roivant Sciences Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Roivant Sciences Ltd across 7 annual periods. See Roivant Sciences Ltd (ROIV) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Roivant Sciences Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for Roivant Sciences Ltd. For the full company profile including market capitalisation, see Roivant Sciences Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.34x | $-834.85 Million | $-839.45 Million | $249.74 Million | ▼ -238.7% |
| 2024 | -0.99x | $-763.89 Million | $-765.27 Million | $773.95 Million | ▲ +7.1% |
| 2023 | -1.06x | $-830.70 Million | $-843.39 Million | $782.02 Million | ▲ +15.7% |
| 2022 | -1.26x | $-660.29 Million | $-677.73 Million | $523.70 Million | ▼ -21.8% |
| 2021 | -1.04x | $-546.33 Million | $-552.14 Million | $527.69 Million | ▲ +49.6% |
| 2020 | -2.05x | $-756.92 Million | $-761.83 Million | $368.36 Million | ▲ +8.6% |
| 2019 | -2.25x | $-1.01 Billion | $-1.02 Billion | $450.51 Million | — |